Replacement: Issue of Equity and TVR | 27-Aug-2025 | 07:01 | RNS |
Resolution of Legacy Defect Notifications | 27-Aug-2025 | 07:00 | RNS |
Issue of Equity and Total Voting Rights | 26-Aug-2025 | 15:51 | RNS |
Appointment of CFO | 22-Aug-2025 | 12:50 | RNS |
AIM Rule 17 and Schedule 2(g) Update | 19-Aug-2025 | 16:06 | RNS |
New Contract Awards | 18-Aug-2025 | 07:00 | RNS |
Directorate Change | 13-Aug-2025 | 07:00 | RNS |
Contract Award for Middle East Project | 09-Jul-2025 | 07:00 | RNS |
Unaudited Interim Results | 26-Jun-2025 | 07:00 | RNS |
Contract Win | 12-May-2025 | 07:00 | RNS |
Receipt of deferred consideration | 09-May-2025 | 13:50 | RNS |
Holding(s) in Company | 04-Apr-2025 | 18:28 | RNS |
Result of AGM | 27-Mar-2025 | 10:20 | RNS |
Grant of Conditional Share Options | 26-Mar-2025 | 11:48 | RNS |
Launch of SAYE Scheme | 24-Mar-2025 | 15:15 | RNS |
Currency | UK Pounds |
Share Price | 5.54p |
Change Today | -0.083p |
% Change | -1.48 % |
52 Week High | 9.50p |
52 Week Low | 4.25p |
Volume | 5,011 |
Shares Issued | 138.89m |
Market Cap | £7.70m |
RiskGrade | 392 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
CEO | Richard Turner |
CFO | Philip Lanigan |
You are here: research